We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-12.59%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$6.47B
AUM Growth
-$1.17B
Cap. Flow
+$229M
Cap. Flow %
3.54%
Top 10 Hldgs %
71.2%
Holding
88
New
3
Increased
8
Reduced
7
Closed
12

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$271M
2
CRM icon
Salesforce
CRM
+$190M
3
LI icon
Li Auto
LI
+$121M
4
YSG
Yatsen Holding
YSG
+$113M
5
ENFN
Enfusion, Inc.
ENFN
+$101M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$205M
2
BEAM icon
Beam Therapeutics
BEAM
+$126M
3
BABA icon
Alibaba
BABA
+$106M
4
ILMN icon
Illumina
ILMN
+$68M
5
BILI icon
Bilibili
BILI
+$42.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.41%
2 Consumer Discretionary 29.78%
3 Technology 11.51%
4 Communication Services 4.08%
5 Consumer Staples 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$33.9B
$1.48B 22.91%
5,472,259
ONON icon
2
On Holding
ONON
$12.6B
$604M 9.33%
15,973,750
LEGN icon
3
Legend Biotech
LEGN
$3.64B
$550M 8.5%
11,804,925
+750,000
+7% +$38M
CRM icon
4
Salesforce
CRM
$155B
$490M 7.58%
1,929,876
+675,700
+54% +$190M
NBP
5
NovaBridge Biosciences American Depositary Shares
NBP
$191M
$340M 5.26%
7,182,850
JD icon
6
JD.com
JD
$43.2B
$334M 5.16%
4,767,307
SE icon
7
Sea Limited
SE
$66.2B
$277M 4.28%
1,237,800
+907,800
+275% +$271M
DASH icon
8
DoorDash
DASH
$85B
$193M 2.98%
1,296,300
+100,000
+8% +$18.9M
IQ icon
9
iQIYI
IQ
$1.2B
$176M 2.72%
38,648,477
LI icon
10
Li Auto
LI
$14.4B
$161M 2.48%
5,007,300
+3,927,300
+364% +$121M
CTKB icon
11
Cytek Biosciences
CTKB
$563M
$143M 2.21%
8,757,030
MDLZ icon
12
Mondelez International
MDLZ
$83.8B
$123M 1.91%
1,862,164
ENFN
13
DELISTED
Enfusion, Inc.
ENFN
$104M 1.61%
+4,975,183
New +$101M
BEKE icon
14
KE Holdings
BEKE
$17.6B
$101M 1.56%
5,012,100
BBIO icon
15
BridgeBio Pharma
BBIO
$16.5B
$89.4M 1.38%
5,362,014
YSG
16
Yatsen Holding
YSG
$312M
$87M 1.34%
8,090,343
+8,040,190
+16,031% +$113M
GOSS icon
17
Gossamer Bio
GOSS
$92.8M
$83.9M 1.3%
7,420,974
VIPS icon
18
Vipshop
VIPS
$7.22B
$75.3M 1.16%
8,963,752
ERAS icon
19
Erasca
ERAS
$5.98B
$73.6M 1.14%
4,722,221
CPNG icon
20
Coupang
CPNG
$27.4B
$71.3M 1.1%
2,425,200
+244,928
+11% +$6.9M
PLTK icon
21
Playtika
PLTK
$1.52B
$56.7M 0.88%
3,280,699
AMG icon
22
Affiliated Managers Group
AMG
$9.59B
$55.1M 0.85%
335,073
AMZN icon
23
Amazon
AMZN
$2.46T
$50M 0.77%
+300,000
New +$51.3M
UBER icon
24
Uber
UBER
$143B
$46.7M 0.72%
1,114,000
TSM icon
25
TSMC
TSM
$1.95T
$43.4M 0.67%
360,495

Similar funds

HHLR Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, HHLR Advisors held 88 positions worth $6.47B, down 15% from $7.65B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

HHLR Advisors deployed $229M of net new capital in Q4 2021, opening 3 new positions and adding to 8 existing holdings. Its largest new stake was Enfusion, Inc.: 4,975,183 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 58% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Pinduoduo, an estimated $205M trimmed.

  • HHLR Advisors's largest Q4 2021 buy was Enfusion, Inc.: 4,975,183 shares worth $104M.
  • HHLR Advisors added most to Sea Limited in Q4 2021, an estimated $271M increase.
  • HHLR Advisors's biggest Q4 2021 reduction was Pinduoduo, cutting an estimated $205M.
  • HHLR Advisors fully exited Beam Therapeutics in Q4 2021, selling an estimated $126M.
  • HHLR Advisors's ten largest holdings make up 71% of its $6.47B portfolio in Q4 2021.
  • HHLR Advisors opened 3 new positions and closed 12 in Q4 2021.
  • HHLR Advisors's portfolio value fell 15% quarter-over-quarter to $6.47B.

Based on HHLR Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.